Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1985-12-18
1987-05-05
Terapane, John F.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
A61K 3155
Patent
active
H00002712
ABSTRACT:
A method of treating animals for the control of malaria using the esters of cephalotaxine--harringtonine, homoharringtonine and deoxyharringtonine.
REFERENCES:
patent: 3870727 (1975-03-01), Powell et al.
patent: 3959312 (1976-05-01), Mikolajczak et al.
patent: 4203996 (1980-05-01), Mikolajczak et al.
Homoharringtonine NSC 141633, published by Investigational Drug Branch Car Therapy Evaluation Program Division of Cancer Treatment National Cancer Institute, Bethesda, Maryland, Jul. 1, 1981, revised Aug. 1982.
Coonley et al., Cancer Treatment Reports, vol. 67, pp. 693-696 (1983).
Warrell et al., Journal of Clinical Oncology, vol. 3, pp. 617-621 (1985) by American Society of Clinical Oncology.
Porcari Damian
Taucher Peter A.
Terapane John F.
The United States of America as represented by the Secretary of
Thomas J. E.
LandOfFree
Treatment of malaria with esters of cephalotaxine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of malaria with esters of cephalotaxine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of malaria with esters of cephalotaxine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2391620